|Articles|May 30, 2006

Coming Soon

Q&A Coming Soon!

Newsletter

Stay prepared and protected with the Infection Control Today newsletter, delivering essential updates, best practices, and expert insights for infection prevention professionals.

Subscribe

Related Content

Person washing hands. (Adobe Stock 200575602 By kieferpix)

From “Gotcha” to Coaching: Using RTLS to Improve Hand Hygiene

ByTori Whitacre Martonicz, MA

August 11th 2026

Copacabana Beach and Ipanema Beach in Rio de Janeiro, Brazil (Adobe Stock 193839900 by f11photo)

AIDS 2026: Malawi Program Achieves 10-fold Reduction in HIV Positivity Among Exposed Infants

ByTori Whitacre Martonicz, MA

August 10th 2026

Paper with urinary tract infection written on it and pills. (Adobe Stock 82815499 by Vitalii Vodolazskyi)

Global $17 Million Trial to Evaluate Phage Therapy for Drug-Resistant Recurrent UTIs

ByInfection Control Today® Editorial Staff

August 10th 2026

Sick baby boy applying inhaled medication by inhalation mask to cure Respiratory Syncytial Virus (RSV) on the patient's bed at the hospital. (Adobe Stock 262979486 by zilvergolf)

FDA Accepts Merck Application to Expand ENFLONSIA Protection Into Second RSV Season

ByInfection Control Today® Editorial Staff

August 10th 2026

Microscopic view of Cyclospora cayetanensis oocysts under magnification, stained bright red. cyclosporiasis outbreak, foodborne parasites, intestinal infections. water pollution. (Adobe Stock 2122448953 by alones)

Roche Expands Cyclospora PCR Testing Portfolio to Support Ongoing US Outbreak Response

ByInfection Control Today® Editorial Staff

August 7th 2026

Latest CME

Multimedia

Empowering HIV Management: Evidence-Based Prevention and Treatment Strategies

Onyema Ogbuagu, MD, FACP, FIDSA

Coming Soon

Related Content

From “Gotcha” to Coaching: Using RTLS to Improve Hand Hygiene

AIDS 2026: Malawi Program Achieves 10-fold Reduction in HIV Positivity Among Exposed Infants

Global $17 Million Trial to Evaluate Phage Therapy for Drug-Resistant Recurrent UTIs

FDA Accepts Merck Application to Expand ENFLONSIA Protection Into Second RSV Season

Roche Expands Cyclospora PCR Testing Portfolio to Support Ongoing US Outbreak Response

Latest CME

Empowering HIV Management: Evidence-Based Prevention and Treatment Strategies

Trending on Infection Control Today

From “Gotcha” to Coaching: Using RTLS to Improve Hand Hygiene

Global $17 Million Trial to Evaluate Phage Therapy for Drug-Resistant Recurrent UTIs

AIDS 2026: Malawi Program Achieves 10-fold Reduction in HIV Positivity Among Exposed Infants

Roche Expands Cyclospora PCR Testing Portfolio to Support Ongoing US Outbreak Response

FDA Accepts Merck Application to Expand ENFLONSIA Protection Into Second RSV Season